The Journal of Conventional Weapons Destruction Issue 27.2

Updates on recent enhancements to IMAS. Food security and its connection to mine action as it applies to Ukraine. Digital EORE as a small NGO in mine action. A case study on moving beyond do no harm in environmental mainstreaming in mine action. Efforts of JICA and CMAC in fostering South-South cooperation in mine action. UAV Lidar imaging in mine action to detect and map minefields in Angola. Land disputes and rights in mine action. Computer vision detection of explosive ordnance

The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/110888/1/ana23986.pd

介護老人福祉施設におけるユニット型施設と従来型施設の介護職員の業務量の比較による業務内容と業務負担との関連性に関する研究

介護老人福祉施設におけるユニット型と従来型の介護職員の業務実態とその負担度との関連性について自計式タイムスタディ調査結果から比較検証した。ケアワークコードで分類される「移動・移乗・体位交換」および「排泄」は介護職員一人あたりの業務発生回数の多さと負担度の高さから，従来型施設の介護職員の業務負担を考察する上で重要な項目であることが示唆された。また，「医療」の項目はその発生回数の多さから，「入浴・清潔保持整容・更衣」の項目はその負担度の高さから，ユニット型施設の介護職員の業務を特徴づける項目であることが示唆された。We conducted a comparative study of the care staff of unit-type and conventional-type special nursing homes for the elderly regarding the relation between their actual conditions and their workload from the results of a self-reported time study. From care work code analysis, it was suggested that “movement, transfer and position change”, as well as excretion, were important items for considering the burden of the care staff in the conventional-type facilities from the frequency and the burden level. The frequency of medical treatment and the burden level of bathing, keeping clean and changing clothes were suggested to be items which characterized the work of the care staff in the unit-type facilities.報

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.

The coexistence of type 2 diabetes mellitus (T2DM) and heart failure (HF), either with reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30-40% of patients) and associated with a higher risk of HF hospitalization, all-cause and cardiovascular (CV) mortality. The most important causes of HF in T2DM are coronary artery disease, arterial hypertension and a direct detrimental effect of T2DM on the myocardium. T2DM is often unrecognized in HF patients, and vice versa, which emphasizes the importance of an active search for both disorders in the clinical practice. There are no specific limitations to HF treatment in T2DM. Subanalyses of trials addressing HF treatment in the general population have shown that all HF therapies are similarly effective regardless of T2DM. Concerning T2DM treatment in HF patients, most guidelines currently recommend metformin as the first-line choice. Sulphonylureas and insulin have been the traditional second- and third-line therapies although their safety in HF is equivocal. Neither glucagon-like preptide-1 (GLP-1) receptor agonists, nor dipeptidyl peptidase-4 (DPP4) inhibitors reduce the risk for HF hospitalization. Indeed, a DPP4 inhibitor, saxagliptin, has been associated with a higher risk of HF hospitalization. Thiazolidinediones (pioglitazone and rosiglitazone) are contraindicated in patients with (or at risk of) HF. In recent trials, sodium-glucose co-transporter-2 (SGLT2) inhibitors, empagliflozin and canagliflozin, have both shown a significant reduction in HF hospitalization in patients with established CV disease or at risk of CV disease. Several ongoing trials should provide an insight into the effectiveness of SGLT2 inhibitors in patients with HFrEF and HFpEF in the absence of T2DM

State of New-Hampshire, July 4, 1808. Sir. Impressed with a sense of dangers to which our country is exposed the Republicans of the Legislature when at Concord, assembled to deliberate on the momentous subject ... By transmitting you the enclose

Page Order: Folde